CardioDigital

CardioDigital, Ltd mainly engages in the research and development of time-frequency-based medical signal analysis, monitoring, and predictive analytics methods. The company's products include COP, an index used to predict cardioversion outcomes during clinical decision-making; PlethRESP, which can directly detect respiration from the pleth waveform; and a method for deriving oxygen saturation measurements in wavelet space using NovoSAT. It also provides consulting services to individual companies. The company was founded in 2000 and is headquartered in Avon, UK.